Bardin Hill Management Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-253,299
Closed -$44.9M 37
2020
Q1
$44.9M Sell
253,299
-95,135
-27% -$17.9M 9.81% 3
2019
Q4
$66.6M Buy
348,434
+98,952
+40% +$17.9M 10.96% 2
2019
Q3
$42M Buy
249,482
+165,349
+197% +$26.9M 7.28% 5
2019
Q2
$14.1M Buy
+84,133
New +$11.6M 1.95% 18
2015
Q3
Sell
-14,394
Closed -$4.37M 78
2015
Q2
$4.37M Sell
14,394
-31,345
-69% -$9.35M 0.6% 37
2015
Q1
$13.6M Buy
+45,739
New +$13M 1.94% 11

Other funds holding AGN

Bardin Hill Management Partners's AGN Position: Q2 2020 in Review

Bardin Hill Management Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 253,299 shares — an estimated $44.9M sold.

Bardin Hill Management Partners first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $66.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bardin Hill Management Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bardin Hill Management Partners sold 253,299 Allergan plc shares in Q2 2020, an estimated $44.9M.
  • Bardin Hill Management Partners first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Bardin Hill Management Partners's Allergan plc position peaked at $66.6M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bardin Hill Management Partners's 13F filing for Q2 2020, filed 14 Aug 2020.